Kim, J.; Lee, T.S.; Lee, M.H.; Cho, I.R.; Ryu, J.K.; Kim, Y.-T.; Lee, S.H.; Paik, W.H.
Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib. Cancers 2024, 16, 1056.
https://doi.org/10.3390/cancers16051056
AMA Style
Kim J, Lee TS, Lee MH, Cho IR, Ryu JK, Kim Y-T, Lee SH, Paik WH.
Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib. Cancers. 2024; 16(5):1056.
https://doi.org/10.3390/cancers16051056
Chicago/Turabian Style
Kim, Junyeol, Tae Seung Lee, Myeong Hwan Lee, In Rae Cho, Ji Kon Ryu, Yong-Tae Kim, Sang Hyub Lee, and Woo Hyun Paik.
2024. "Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib" Cancers 16, no. 5: 1056.
https://doi.org/10.3390/cancers16051056
APA Style
Kim, J., Lee, T. S., Lee, M. H., Cho, I. R., Ryu, J. K., Kim, Y. -T., Lee, S. H., & Paik, W. H.
(2024). Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib. Cancers, 16(5), 1056.
https://doi.org/10.3390/cancers16051056